Cytocare Inc.: The Irvine urologic pharmaceutical and...
- Share via
Cytocare Inc.: The Irvine urologic pharmaceutical and device company reported net earnings of $388,596 for the first quarter, equal to 8 cents per share, on revenue of $3.3 million. This compares to first-quarter 1991 earnings of $501,534, or 10 cents per share, on revenue of $2.5 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
